CDE ID | CDE Description | * 1063 | Site Participant ID (Go To: 422) |
* 422 | EDRN Site ID (Go To: 423) |
* 423 | EDRN Protocol ID (Go To: 1219) |
* 1219 | Date of contact (MM/DD/YYYY): (Go To: 2655) |
* 2655 | Proposed study group (Go To: 1292) |
| Permissible Values (value): | Set A Cases: Lung cancer (1) |
|
| | Set A Controls: High Risk (3) |
|
| | Set A Controls: Other cancers (5) |
|
1292 | Height [in inches] (What is your total current height in inches?) (Go To: 1295) |
1295 | Weight [in pounds] (What is your current weight [in pounds]? (Go To: 1216) |
* 1216 | Date of diagnosis of lung cancer (histological or cytopathological report) (MM/DD/YYYY): (Go To: 3174) |
3174 | Date (YYYY) of diagnosis of lung cancer (histological or cytopathological report) (Go To: 1302) |
1302 | Age at diagnosis (Go To: 1220) |
1338 | Histologic confirmation? (Go To: 1257) |
| Permissible Values (value): | No (0) |
|
| |
1257 | Histologic type (lung): (Go To: 1241) |
| Permissible Values (value): | Squamous cell carcinoma (1) |
|
| | Papillary squamous cell carcinoma (2) |
|
| | Clear cell squamous cell carcinoma (3) |
|
| | Small cell squamous cell carcinoma (4) |
|
| | Basaloid squamous cell carcinoma (5) |
|
| |
| | Combined small cell carcinoma (7) |
|
| |
| | Acinar adenocarcinoma (9) |
|
| | Papillary adenocarcinoma (10) |
|
| | Bronchioloalveolar carcinoma (11) |
|
| |
| |
| | Mixed mucinous and non-mucinous or indeterminate (14) |
|
| | Solid adenocarcinoma with mucin formation (15) |
|
| | Adenocarcinoma with mixed subtypes (16) |
|
| | Large cell carcinoma (17) |
|
| |
| |
1241 | Histologic dimensions - height (cm): (Go To: 1242) |
1242 | Histologic dimensions - width (cm): (Go To: 1243) |
1243 | Histologic dimensions - depth (cm): (Go To: 1244) |
1244 | Histologic dimensions - volume (ml): (Go To: 1245) |
1245 | Distance/pleural margin (mm): (Go To: 1246) |
1246 | Distance/bronchial margin (mm): (Go To: 720) |
720 | Anatomical site (Go To: 1217) |
| Permissible Values (value): | Bladder (1) |
|
| |
| | Bowel peritoneum/serosa (3) |
|
| |
| |
| |
| |
| |
| |
| |
| |
| | Peritoneum/uterine serosa (12) |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | Responses are organ-specific (999) |
|
1217 | Date of thoracotomy (MM/DD/YYYY): (Go To: 1234) |
1234 | Chest X-ray date (MM/DD/YYYY): (Go To: 1235) |
1235 | Chest X-ray nodule size (cm): (Go To: 1236) |
1236 | Chest X-ray nodule location: (Go To: 2656) |
2656 | Chest X-ray nodule shape: (Go To: 1237) |
| Permissible Values (value): | Smooth (0) |
|
| |
| |
| |
1237 | Chest CT date: (Go To: 1238) |
1238 | Chest CT nodule size (cm): (Go To: 1239) |
1239 | Chest CT nodule location: (Go To: 2657) |
2657 | CT nodule shape: (Go To: 1268) |
| Permissible Values (value): | Smooth (0) |
|
| |
| |
| |
1268 | PET scan date (MM/YYYY): (Go To: 1269) |
1269 | PET scan standardized uptake value (SUV) for the lesion: (Go To: 1273) |
| Permissible Values (value): | Less than 2.5 (1) |
|
| | Greater than or equal to 2.5 (2) |
|
1273 | PET scan standardized uptake value (SUV) for the liver: (Go To: 1274) |
1274 | PET scan other hotspots: (Go To: 786) |
| Permissible Values (value): | Mediastinum (1) |
|
| |
| |
| |
| |
| |
| |
786 | Lung T-Stage, Pathologic (Go To: 789) |
| Permissible Values (value): | pTX (1) |
|
| |
| |
| |
| |
| |
| |
789 | Lung N-Stage, Pathologic (Go To: 790) |
| Permissible Values (value): | pNX (1) |
|
| |
| |
| |
| |
790 | Lung M-Stage, Pathologic (Go To: 785) |
| Permissible Values (value): | pMX (1) |
|
| |
| |
785 | Lung T-Stage, Clinical (Go To: 787) |
| Permissible Values (value): | TX (1) |
|
| |
| |
| |
| |
| |
| |
787 | Lung N-Stage, Clinical (Go To: 788) |
| Permissible Values (value): | NX (1) |
|
| |
| |
| |
| |
788 | Lung M-Stage, Clinical (Go To: 1240) |
| Permissible Values (value): | MX (1) |
|
| |
| |
1240 | Reported adenopathy > 1 cm in the mediastinum at time of diagnosis? (Go To: 1268) |
| Permissible Values (value): | No (0) |
|
| |
| |
1266 | Other lung diseases participant has: (Go To: 1249) |
| Permissible Values (value): | COPD (1) |
|
| |
| |
| |
| |
| |
| |
1249 | Pulmonary function test date (MM/DD/YYYY): (Go To: 1250) |
1250 | FVC liters (Go To: 1251) |
1251 | FVC % predicted: (Go To: 1252) |
1252 | FEV1 liters: (Go To: 1253) |
1253 | FEV1 % predicted: (Go To: 1254) |
1254 | FEV1/FVC (Go To: 1255) |
1255 | DLCO liters/minute/mmhg (Go To: 1256) |
1256 | DLCO % predicted: (Go To: 2148) |
2148 | Primary cancer treatment(s) received: (Go To: 1258) |
| Permissible Values (value): | Chemotherapy (1) |
|
| |
| |
| |
| |
| | LHRH agonists or anti-androgens hormone therapy (6) |
|
| | Other hormone therapy (e.g. testosterone patch) (7) |
|
| |
| |
| |
1258 | Chemotherapy treatment(s) received: [specify drug(s)] (Go To: 1259) |
1259 | Chemotherapy start date (MM/YYYY): (Go To: 1260) |
1260 | Chemotherapy end date (MM/YYYY): (Go To: 1261) |
1261 | Radiation therapy received: (specify site) (Go To: 1262) |
1262 | Radiation therapy start date: (MM/YYYY): (Go To: 1263) |
1263 | Radiation therapy end date: (MM/YYYY): (Go To: 1264) |
1264 | Total dose to chest: (cGy) (Go To: 1265) |
1265 | Total dose to other organ(s): (cGy) (Go To: 1282) |
1282 | Radiation therapy (RT) volume [cubic mm]: (Go To: 1281) |
1281 | Radiation therapy (RT) complications: (Go To: 1279) |
| Permissible Values (value): | Pneumonitis requiring steroids (1) |
|
| | Esophagitis requiring IVF (2) |
|
| |
| |
| |
1279 | Response to treatment (imaging criteria) (Go To: 1278) |
| Permissible Values (value): | No (0) |
|
| |
1278 | Date of response (MM/DD/YYYY): (Go To: 1221) |
1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |